These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34167853)

  • 41. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
    Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
    Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y; Yin J; Guo D; Lang X; Wang X
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):159-67. PubMed ID: 21166726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
    Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
    Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brucella melitensis M5-90Δbp26 as a potential live vaccine that allows for the distinction between natural infection and immunization.
    Li T; Tong Z; Huang M; Tang L; Zhang H; Chen C
    Can J Microbiol; 2017 Aug; 63(8):719-729. PubMed ID: 28482164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.
    Shirdast H; Ebrahimzadeh F; Taromchi AH; Mortazavi Y; Esmaeilzadeh A; Sekhavati MH; Nedaei K; Mirabzadeh E
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):80-89. PubMed ID: 32661939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.
    Moustafa D; Garg VK; Jain N; Sriranganathan N; Vemulapalli R
    Vaccine; 2011 Jan; 29(4):784-94. PubMed ID: 21109033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.
    Bugybayeva D; Kydyrbayev Z; Zinina N; Assanzhanova N; Yespembetov B; Kozhamkulov Y; Zakarya K; Ryskeldinova S; Tabynov K
    Infect Dis Poverty; 2021 Feb; 10(1):13. PubMed ID: 33593447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
    Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
    World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.
    Lalsiamthara J; Lee JH
    Vet Microbiol; 2017 Jun; 205():84-91. PubMed ID: 28622869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
    Abkar M; Alamian S; Sattarahmady N
    Immunol Lett; 2019 Mar; 207():28-35. PubMed ID: 30707922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing
    Bugybayeva D; Ryskeldinova S; Zinina N; Sarmykova M; Assanzhanova N; Kydyrbayev Z; Tabynov K
    Biomed Res Int; 2020; 2020():1438928. PubMed ID: 33274194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
    Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
    Yang X; Walters N; Robison A; Trunkle T; Pascual DW
    Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
    Delpino MV; Estein SM; Fossati CA; Baldi PC
    Clin Vaccine Immunol; 2007 Oct; 14(10):1296-301. PubMed ID: 17715332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
    Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.
    Kahl-McDonagh MM; Ficht TA
    Infect Immun; 2006 Jul; 74(7):4048-57. PubMed ID: 16790778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
    Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
    Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.